Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: The story describes the cost of the drug-coated stents compared to the older version, the bare metal stents. The story does report the risk of clotting with the drug-coated stents, however the comparison of coated and bare metal stents is the key piece of information that is missing in this story. This information should also be presented in absolute rather than relative terms. The story adequately describes the risk of clotting with drug-coated stents and of bleeding with Plavix. The story does a good job of describing the strength of the available evidence, particularly the limitations of using hospital registries as a source of data. By accurately describing the prevalence of restenosis, or narrowing of the artery after stenting, the story avoids disease mongering. The story quotes multiple experts who have differing perspectives on how the new information changes clinical practice. The story does mention alternatives such as bare metal stents, bypass surgery and medications. The story clearly states that drug-coated stents are common. The story clearly states that the drug-coated stents are new but have been widely used since they were introduced. Because the story quotes multiple independent sources the reader can assume that the story does not rely on a press release as the sole source of information.
[A]: FDA Probes Safety of Popular Heart Stent


[Q]: London’s Metropolitan Police said the company had been charged with seven counts of supplying a medicinal product which was not of the nature or quality specified in the prescription. It was also accused of failing to take all reasonably practicable steps to ensure that patients were not infected by contaminants. The north London company said in a statement: “As founders of ITH we have every sympathy for all the families affected, regardless of the cause. However, we are disappointed by the decision to charge the company and will vigorously defend this case.”  The police investigation was launched in September 2014 following the death of a baby three months earlier at London’s Guy’s and St Thomas’ hospital. The death of a second baby at the same hospital and a third at the Rosie Maternity Hospital in Cambridge, central England, in June 2014 were then also investigated. The inquiry followed an outbreak of a bacterial infection that affected some babies receiving Total Parental Nutrition (TPN), an intravenous feed. The seven babies involved in the investigation, including the three who died, had all received the feed. The investigation established that the cause of death of the first baby could be linked to TPN, although the deaths of the other two were not found to be linked. Five hospitals in total were involved in the investigation, the other three being Russells Hall Hospital in Dudley, Luton and Dunstable Hospital and Lister Hospital in Stevenage, all in central England. ITH Pharma, which was founded in 2008, said it had manufactured more than 1.4-million components of TPN since its launch and was the sole commercial supplier of reactive feeding solutions to the National Health Service. “This product has helped thousands of extremely vulnerable infants survive premature and complex births,” it said. The case is due to start at Westminster Magistrates’ Court in London on Dec. 17.
[A]: UK police charge pharmaceutical company over hospital baby deaths.


[Q]: The Wildlife Department in eastern Sabah state on Borneo island said the rhino, named Iman, died of natural causes Saturday due to shock in her system. She had uterine tumors since her capture in March 2014. Department director Augustine Tuuga said in a statement that Iman, who reportedly was 25 years old, was suffering significant pain from growing pressure of the tumors to her bladder but that her death came sooner than expected. It came six months after the death of the country’s only male rhino in Sabah. Another female rhino also died in captivity in 2017 in the state. Efforts to breed them have been futile but Sabah authorities have harvested their cells for possible reproduction. “Despite us knowing that this would happen sooner rather than later, we are so very saddened by this news,” said Sabah Deputy Chief Minister Christina Liew, who is also environment minister. Liew said that Iman had escaped death several times over the past few years due to sudden massive blood loss, but that wildlife officials managed to nurse her back to health and obtained her egg cells for a possible collaboration with Indonesia to reproduce the critically endangered species through artificial insemination. The Sumatran rhino, the smallest of five rhinoceros species, once roamed across Asia as far as India, but its numbers have shrunk drastically due to deforestation and poaching. The WWF conservation group estimates that there are only about 80 left, mostly living in the wild in Sumatra and Borneo in Indonesia. The International Union for the Conservation of Nature identifies the Sumatran as well as the Black and Javan rhinoceros as being critically endangered. Both African and Sumatran rhinoceros have two horns, while the others have a single horn. Only about 24,500 rhinos survive in the wild with another 1,250 in captivity worldwide, the IUCN says. Of these, more than two-thirds are white rhinos. Rhinos are killed for their horns, which consist of keratin similar to human hair and nails and are used in traditional medicines in parts of Asia.
[A]:
Sumatran rhino is extinct in Malaysia as lone survivor dies.